That is not a scare tactic
Diabetes, metabolic syndrome and obesity : targets and therapy, 15, 10231030
J Neurosurg 143:10371047, 2025 This multicenter propensity-matched cohort study examines the association between glucagon-like peptide-1 receptor agonist (GLP-1-RA) therapy and clinical, neurosurgical, and mortality outcomes in adult patients with idiopathic intracranial hypertension (IIH) using the TriNetX electronic health record network
Rush it and you stack two potent GLP-1 medications on top of each other, amplifying side effects
Clinical outcomes depend on dose, consistency, and patient adherencefactors controlled through PlexusDx's telehealth monitoring
[DOI] [PubMed] [Google Scholar] 57.Torres-Mora J., Ud Din N., Ahrens W.A., Folpe A.L